Epidemiology of Diabetes Mellitus in Pregnancy in Hungary: Trends and Future Projections
Author(s)
Tímea Csákvári, BSc, MSc, PhD1, Diána Elmer, BSc, MSc, PhD1, Krisztina Palkovics, BSc, MSc1, Luca Fanni Kajos, BSc, MSc, PhD1, Kálmán Kovács, MD, PhD2, József Bódis, MD, PhD2, Imre Boncz, MSc, PhD, MD1.
1Institute for Health Insurance, University of Pécs, Pécs, Hungary, 2Department of Obstetrics and Gynaecology, Clinical Centre, University of Pécs, Pécs, Hungary.
1Institute for Health Insurance, University of Pécs, Pécs, Hungary, 2Department of Obstetrics and Gynaecology, Clinical Centre, University of Pécs, Pécs, Hungary.
OBJECTIVES: Diabetes in pregnancy represents a significant public health concern with established impacts on both maternal health outcomes. Our aim was to evaluate the epidemiology of diabetes mellitus in pregnancy (DMP) in Hungary, as well as to project future trends between 2010 and 2035.
METHODS: A retrospective study was conducted using nationwide real-world data from the Hungarian ’Pulvita’ Health Data Warehouse. ICD-10 codes O24.0-O24.9 (DMP) were used to identify patients in outpatient and inpatient care. Annual patient numbers, the number of hospital days, the number of DMP patients per 1,000 women aged 15-49, were analyzed with different forecasting models to project future prevalence up to 2035, using SPSS 27.0.
RESULTS: Between 2010 and 2024, a total of 131,574 patients were registered in outpatient care with DMP, an average of 10,121 patients per year. Based on the trends projected by the model, a decline in outpatient numbers is anticipated, potentially decreasing to as few as 6,178 patients by 2035. During the study period, a total of 98,086 patients were treated for DMP in inpatient care, with an annual average of 6,539 patients, 91.44% of them were diagnosed with gestational diabetes. The number of DMP cases per 1,000 women aged 15-49 exhibit an increasing trend, and further growth is projected between 2025 and 2035. In 2010, there were 1.97 DMP per 1,000 women of reproductive age, rising to 3.44 by 2024. Our projections indicate that this figure could increase to 4.60 by 2035.
CONCLUSIONS: Although the absolute number of DMP cases shows a decline in both outpatient and inpatient care, population-adjusted analyses project the opposite: the prevalence among women aged 15-49 is likely to increase. It is therefore warranted for policymakers to reconsider existing preventive programs, with particular emphasis on strengthening targeted interventions aimed at maternal metabolic health.
METHODS: A retrospective study was conducted using nationwide real-world data from the Hungarian ’Pulvita’ Health Data Warehouse. ICD-10 codes O24.0-O24.9 (DMP) were used to identify patients in outpatient and inpatient care. Annual patient numbers, the number of hospital days, the number of DMP patients per 1,000 women aged 15-49, were analyzed with different forecasting models to project future prevalence up to 2035, using SPSS 27.0.
RESULTS: Between 2010 and 2024, a total of 131,574 patients were registered in outpatient care with DMP, an average of 10,121 patients per year. Based on the trends projected by the model, a decline in outpatient numbers is anticipated, potentially decreasing to as few as 6,178 patients by 2035. During the study period, a total of 98,086 patients were treated for DMP in inpatient care, with an annual average of 6,539 patients, 91.44% of them were diagnosed with gestational diabetes. The number of DMP cases per 1,000 women aged 15-49 exhibit an increasing trend, and further growth is projected between 2025 and 2035. In 2010, there were 1.97 DMP per 1,000 women of reproductive age, rising to 3.44 by 2024. Our projections indicate that this figure could increase to 4.60 by 2035.
CONCLUSIONS: Although the absolute number of DMP cases shows a decline in both outpatient and inpatient care, population-adjusted analyses project the opposite: the prevalence among women aged 15-49 is likely to increase. It is therefore warranted for policymakers to reconsider existing preventive programs, with particular emphasis on strengthening targeted interventions aimed at maternal metabolic health.
Conference/Value in Health Info
2025-11, ISPOR Europe 2025, Glasgow, Scotland
Value in Health, Volume 28, Issue S2
Code
EPH82
Topic
Epidemiology & Public Health, Health Policy & Regulatory, Health Service Delivery & Process of Care
Topic Subcategory
Public Health
Disease
Diabetes/Endocrine/Metabolic Disorders (including obesity)